Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories shareholding disclosures
57 filed, newest first. Page 1 of 2.
Jul 2026
Oct 2025
Apr 2025
May 2024
May 2023
Apr 2022
May 2021
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Apr 2015
Jul 2014
Apr 2014
Mar 2014
Feb 2014
Jan 2014
Jul 2013
Sep 2011
Aug 2009
5 Aug · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the (as per list attached), who are Directors, have intimated the company on August 05, 2009, stating that their holdings have changed consequent to the allotment of equity shares as bonus shares in the proportion of one equity share for every one equity share held by them in the company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
3 Nov · Disclosure
Details as per the SEBI (Prohibition of Insider Trading) Regulation, 2002, regarding the insider, who is Director, has intimated the company on October 31, 2008, stating that his holding has changed consequent to the allotment of equity shares under Employee Stock Option Scheme 2006 of the company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
5 Sep · Disclosure
Details as per the SEBI (Prohibition of Insider Trading) Regulation, 2002.The insider who is Director, have intimated the company on September 04, 2008, stating that he has sold the equity shares held by him in the company. Name of Director: Dr. P Gundu Rao; Sell Quantity: 3000 equity shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
30 Apr · Disclosure
Two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2008 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Apr · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations 2002, the following, who are Director ,have intimated the Company, stating that their holdings have changed consequent to the allotment of equity shares under Employee Stock Option Scheme 2006 of the Company: (1) Name of the Director : Mr N V Ramana - Executive Director; No. of Shares allotted: 59175; Date of allotment :- 19.04.2008; Balance holding : 329425; (2) Name of the Director : Dr P Gundu Rao - Director (R&D); No. of Shares allotted: 3550; Date of allotment :- 19.04.2008; Balance holding : 363511 Apr · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director / dependent family member of a Director, have intimated the company on 9th April 2008, stating that they have sold the equity shares held by them in the Company: (1) Name of the Director/Dependent Family Member : Dr. P Gundu Rao; No. of Shares Sold: 1200; Date of Execution :- 08.04.2008; Balance holding : 85; (2) Name of the Director/Dependent Family Member : Ms P Narmada Rao; No. of Shares Sold: 500; Date of Execution :- 08.04.2008; Balance holding : 25
Feb 2008
12 Feb · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director (Projects) of the company has intimated on 11th February 2008, stating that he has received gift of the following equity shares from his relative: (1) Name of the Director - Madhusudana Rao Divi; No. of Shares :- 20000; Date of Execution :- 09.02.2008; Balance holding :- 154500
Dec 2007
14 Dec · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Executive Director of the company has intimated on 10th December 2007, stating that he has gifted to his relative the following equity shares held by him in the company: (1) Name of the Director - N V Ramana; No. of Shares Gifted - 27340; Date of Execution - 10.12.2007; Balance holding - 20000
Jul 2007
2 Jul · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a dependent family member of a Director has intimated the Company on 27th June 2007, stating that she has sold the equity shares held by her in the company: (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 500; Date of Execution - 22.06.2007; Balance holding - 1052 Jul · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a Director have intimated the company on 27th June 2007, stating that he has sold the equity shares held by him in the company: (1) Name of the Director - Dr P Gundu Rao; No. of Shares sold - 500; Date of Execution - 22.06.2007; Balance holding - 257
Jun 2007
22 Jun · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a dependent family member of a Director has intimated the Company on 18th June 2007, stating that she has sold the equity shares held by her in the company : (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 95; Date of Execution - 14.06.2007; Balance holding - 60522 Jun · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insiders, who are Directors have intimated the company on 18th June 2007, stating that they have sold the equity shares held by them in the company : (1) Name of the Director - Dr P Gundu Rao; No. of Shares sold - 91; Date of Execution - 14.06.2007; Balance holding - 757. (2) Name of the Director - G V Rao; No. of Shares sold - 200; Date of Execution - 13.06.2007; Balance holding - 2008 Jun · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is dependent family member of a Director has intimated on 1st June 2007, stating that she has sold the equity shares held by her in the company : (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 300; Date of Execution - 31.05.2007; Balance holding - 700
May 2007
16 May · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director (R&D) of the company has intimated on 14th May 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of the Director - Dr P Gundu Rao; No. of Shares Gifted - 1000; Date of Execution - 14.05.2007; Balance holding - 8488 May · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee has intimated the company on 7th May 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of Designated Employee - S Chandra Divi; No. of Shares Gifted - 1556; Date of Execution - 05.05.2007; Balance holding - 13485 May · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee has intimated the company on 26th April 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of Designated Employee - S Devendra Rao; No. of Shares Sold - 276; Date of Execution - 25.04.2007; Balance holding - 21644 May · Disclosure
The 'purchase' by the Designated employees in the Annual Disclosure Statement submitted by the Company includes allotment of shares under ESOP Scheme besides the other purchases3 May · Disclosure
Annual disclosure statement of Directors of the Company for the year ended March 31, 2007 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.